Clinical Trial Update: Acarbose Cardiovascular Evaluation Trial [Phase 4]

View source ↗

Summary

A Phase 4 cardiovascular evaluation trial of acarbose, led by the University of Oxford, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Coronary Syndrome
• Impaired Glucose Tolerance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)

Snippet

Sponsor: University of Oxford | Conditions: Coronary Heart Disease, Acute Coronary Syndrome | Phase 4 | Status: COMPLETED